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Review Article 
THE ROLE OF OXYGEN RADICALS IN IMMUNE COMPLEX IN JURY 
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Departments of Surgery* and Pathology,t University of Michigan, Ann Arbor. Michigan 48109 
Abstract--In this review we will summarize our current understanding of the mediation of immune complex 
induced tissue injury. Comparisons will be made between the mediation of IgG versus IgA immune complex injury 
with emphasis on the role that reactive oxygen products derived from leukocytic phagocytic cells play in the 
initiation of the tissue injury. 
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I. INTRODUCTION 
It has long been appreciated that immune complex for- 
mation serves an important protective function for the 
host by the complexing and elimination of infectious 
agents such as viruses or bacteria. In addition, it has 
been appreciated since the early part of this century 
that immune complexes could harm as well as protect 
the host.~-2 The subsequent development of a number 
Address correspondence to Keith T. Oldham, MD, University of 
Michigan, Section of Pediatric Surgery, Room F7516 Mott Chil- 
dren's Hospital, Ann Arbor, MI 48109. 
Requests for reprints should be addressed to Kent J. Johnson, MD, 
University of Michigan Medical School, Department of Pathology, 
1150 West Medical Center Drive, Room 7520B-MSRBI, Ann Arbor, 
Ml 48109. 
Keith T. Oldham, MD, is an Assistant Professor of Surgery in 
the Division of Pediatric Surgery, at The University of Michigan. 
His past research interests have included such areas as hepatic injury 
secondary to trauma or infection. Currently his research is concen- 
trating on the pathophysiology of pancreatitis as well as thermal 
in jury. 
Karen S. Guice, MD, is an Assistant Professor in the Division 
of General Surgery, Department of Surgery at The University of 
Michigan. Her research interests center around the pathophysiology 
of the inflammatory response with a specific interest in the patho- 
physiology of acute pancreatitis and the role of oxygen radicals in 
this system. 
Peter A. Ward, MD, is Professor and Chairman of The Depart- 
ment of Pathology at The University of Michigan. His research 
interests center on immunopathology with specific concentration in 
the area of the role of leukocyte derived oxygen radicals in the 
inflammatory response. 
Kent J. Johnson, MD, is an Associate Professor in The Depart- 
ment of Pathology at The University of Michigan. Trained as an 
immunopathologist, Dr. Johnson's research interests center around 
the role that oxygen radicals play in immune complex injury. 
387 
of experimental models of immune complex induced 
tissue injury, such as serum sickness, further strength- 
ened this hypothesis. It is currently well accepted that 
certain human diseases, in particular autoimmune dis- 
eases such as systemic lupus erythematosus, appear to 
be triggered by immune complex formation and dep- 
osition in tissues. 3-» 
With the development of experimental models of 
immune complex induced tissue injury in the late 1950s 
and 1960s, many laboratories began to look for the 
mediators involved in this type of acute inflammation. 
It soon became apparent that the complement system 
was intimately involved. Studies using the technique 
of complement depletion were protective against the 
development of tissue injury in the Arthus vasculitis 
and anti-GBM nephritis models. 6-8 The major mech- 
anism by which complement appeared to initiate the 
tissue injury in these models was by the local gener- 
ation of the chemotactic peptide C5a and the subse- 
quent attraction of neutrophils into the site. Today we 
know that this is probably not the only mechanism by 
which complement is involved in these reactions. Im- 
mune adherence mechanisms dependent upon comple- 
ment C3b receptors may also be important. There is 
also accumulating evidence that complement may di- 
rectly injure the tissues via the generation of the ter- 
minal complement sequence C5b-C9, otherwise known 
as the "membrane attack complex" (MAC). 9-1° 
Irrespective of the role of the complement system, 
phagocytic cell activation and migration into tissues 
are critical events leading to the development of im- 
mune complex tissue injury. Experimentally, neutro- 
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phil or macrophage depletion is usually protective. 
Histologically, (Fig. 1), infiltrates of neutrophils or 
macrophages are characteristic at sites of immune com- 
plex deposition, i1-15 
Because neutrophils and macrophages appear to 
play a pivotal role in the evolution of immune complex 
injury, attention has been focused upon the mediators 
generated by these cells and upon their relationship to 
the injury. As illustrated in Table 1, these cells produce 
an array of potent biological mediators including ar- 
achidonate products, proteases, cationic proteins and 
reactive oxygen products to name a few. Experimental 
evidence supports the concept that leukocytic reactive 
oxygen products play a pivotal role in the initiation of 
the tissue injury. In this review, we will summarize 
the experimental studies that support the concept of 
oxygen radical involvement in immune complex in- 
duced tissue injury. Specific attention will be directed 
at comparing IgG versus IgA induced injury. Recent 
studies suggest that the effector cells as well as the 
specific oxidant species implicated differ for these two 
classes of immune complex injury. Experimental evi- 
dence will also be presented on the interaction of other 
inflammatory mediators, such as platelet adenine nu- 
cleotide products and macrophage cytokines, on oxy- 
gen radical generation by immune complex stimulated 
leukocytes. Finally, evidence will be presented that 
suggests hot all immune complex induced tissue injury 
is oxygen radical mediated. 
II. IgG IMMUNE COMPLEX INDUCED TISSUE IN JURY 
Because virtually ail of the experimental work done 
on the pathogenesis of immune complex injury has 
been with IgG immune complexes, IgG induced tissue 
injury is often considered synonymous with the general 
topic of immune complex disease. This is probably 
appropriate in that IgG complexes are the predominant 
immunoglobulin in tissues in most immune complex 
diseases. However, it is important to remember that a 
number of human diseases have evidence of involve- 
ment of other immunoglobulin classes, in particular 
IgM or IgA. Recent experimental studies illustrate the 
importance of this distinction, in that the pathogenesis 
of immune complex induced injury appears to differ 
according to class. 
Fig. 1. Skin biopsy from a patient with a hypersensitivity vasculitis illustrating the acute inflammatory response triggered by 
the tissue deposition of immune complexes. (a) Direct immunofluorescence showing IgM deposition in the dermal blood vessels 
and (b) Light microscopy showing the resulting acute inflammation in the vessels with neutrophil infiltration and fibrinoid 
necrosis. 
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Table 1. Biologic mediators produced by neutrophils and macro- 
phages 
I. Neutrophil Products 
A. Oxygen Free Radicals (O j ,  H:O2; etc.) 
B. Neutral Proteinases 
(1) Elastase 
(2) Cathepsin G 
(3) Proteinase 3 
(4) Collagenases 





(5) Cathepsins, B and D 
D. Microbicidal Enzymes 
(1) Myeloperoxidase 
(2) Lysozyme 
E. Arachidonic Acid Metabolites (PGE, Thromoboxanes, Leu- 
kotrienes, etc.) 
F. Other 
(1) Basic Proteins 
(2) Thrombin-Activatmg Material 
(3) Kininogenase 
(4) Surface Protease 
II. Macrophage Products 
A. Proteins 
(1) enzymes: 




(d) lipoprotein lipase 
(e) angiotension converting enzyme 
(f) acid hydrolases 
(2) plasma proteins: 
(a) coagulation proteins 




(a) interleukin- 1 
(b) tumor necrosls factor 
(c) interferon alpha 
(d) angiogenesis factor 
B. Reactive Oxygen Species 
(1) superoxide anion 
(2) hydrogen peroxide 
(3) hydroxyl radical 
C. Bioactive Lipids 
(1) prostaglandin E., 
(2) prostacyclin l: 
(3) thromboxane B2 
(4) leukotriene B4, C4, D», E4 
(5) hydroxyeicosatetraenoic acids 
D. Nucleotides 
(1) thymidine, uracil 
(2) cAMP 
(3) uric acid 
A. In-vitro studies on IgG immune complex 
stimulation of phagocytic cells 
As mentioned previously, immune complex injury 
appears to be induced by the immune complex acti- 
vation of neutrophils and macrophages and their release 
of potent biological mediators including reactive ox- 
ygen products. The most likely mechanism of this ac- 
tivation is through immune complex attachment to the 
cell membrane via the Fc receptor. Attachment is fol- 
lowed by phagocytosis of the complex. 16 In vitro stud- 
ies have demonstrated that IgG immune complexes 
differ markedly in their ability to activate phagocytic 
cells in this fashion. The degree of activation depends 
upon physiochemical properties of the antigen-anti- 
body complexes such as size and ratio of antigen to 
antibody. Relatively soluble IgG immune complexes 
(antigen-antibody ratio 1 : 2) maximally stimulate hu- 
man neutrophils to produce superoxide anion, whereas 
large particulate immune complexes at equivalence 
(antigen-antibody ratio 1:5) are less effective neutro- 
phil activators. 17 Using rat neutrophils, maximal stim- 
ulation of superoxide production by IgG immune 
complexes occurs with complexes at an anti- 
gen: antibody weight ratio of 2 : 1.18 Thus, in the hu- 
man, soluble immune complexes may be as important 
in the initiation of injury as the larger particulate com- 
plexes. Traditionally, the larger particulate complexes 
have been thought to be the most phlogistic because 
of their ability to maximally activate the complement 
system. ~8 
Enhancement of the oxygen radical burst by IgG 
immune complex stimulated neutrophils is seen when 
cytochalasin B is added to the system. 19 The mecha- 
nism by which cytochalasin B causes this enhancement 
is not clear. Cytochalasin B exerts a variety of effects 
on cells. One of these, dissociation of microfilaments, 
induces cytoskeletal alterations, which allow stimuli 
such as immune complexes to activate the cells without 
having to undergo endocytosis. Cytochalasin B is also 
known to enhance calcium flux into cells. 2°-22 What- 
ever the mechanisms involved, there are marked dif- 
ferences when cytochalasin B is added to macrophages 
rather than neutrophils. Instead of enhancing, cyto- 
chalasin B inhibits superoxide production by macro- 
phages stimulated by IgG immune complexes. 23 This 
contrasting effect of cytochalasin B suggests that the 
mechanism of cell activation by IgG immune com- 
plexes is different in neutrophils and macrophages. 
This impression is strengthened by studies described 
in detail below where IgA immune complexes stimulate 
the macrophage but not the neutrophil respiratory 
burst. 
Recent experimental studies have also shown that 
immune complex stimulation of phagocytic cells and 
oxygen radical formation can be potentiated by the 
addition of other inflammatory mediators. Van Epps 
originally showed that pretreatment of neutrophils with 
chemotactic peptides such as C5a would markedly in- 
crease neutrophil superoxide production when subse- 
quently given a second stimulus such as zymosan. 24 
This "potentiation" of oxidant burst activity was con- 
firmed by Speer et. al. who found that pretreatment of 
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macrophages with proteases greatly enhanced the pro- 
duction of superoxide when the cells were subsequently 
stimulated with phorbol myristate acetate (PMA). 25 
Studies in our laboratory have demonstrated similar 
potentiation of neutrophil and macrophage superoxide 
production by C5a when immune complexes were used 
as the second stimulusfl 6 Thus, direct stimulation of 
phagocytic cells by complement products, in particular 
C5a, may be important in the pathogenesis of tissue 
injury. Whether the terminal complement activation 
peptide C5b-C9, otherwise known as the membrane 
attack complex (MAC), can "prime" phagocytic cells 
in a similar fashion as C5a is not known. It is clear, 
however, that the MAC can directly induce oxidant 
generation by these cells under certain conditions. 27 
Other factors have also been described that enhance 
the respiratory burst of phagocytic cells when stimu- 
lated by IgG immune complexes. These include poly- 
electrolyte substances such as cationic histones (e.g., 
polyhistidine and polyarginine), and anionic sub- 
stances (e.g., polyanetholsulfonate). 28-3° The mecha- 
nisms by which these charged substances enhance 
oxygen radical formation by phagocytic cells is not 
known. However, biological relevance has been in- 
ferred from in vivo studies which show that the addition 
of these charged substances enhances immune complex 
mediated tissue injury. 28 
Finally, in the last few years some very exciting 
observations have been forthcoming suggesting that 
inflammatory mediators produced by platelets and 
macrophages enhance oxygen radical production by 
IgG stimulated phagocytic cells. In terms of macro- 
phage-derived cytokines, interleukin 1 (IL-l), and to 
a lessor degree, tumor necrosis factor (TNF), have been 
found to enhance superoxide generation by IgG stim- 
ulated macrophages. This effect is not seen in neutro- 
phils. 26,~8 At the concentrations used, these cytokines 
alone had no direct stimulatory effect on macrophages 
although it has been reported that TNF can directly 
stimulate neutrophils to generate superoxide. 3~ Platelet 
factors have also been found to enhance the oxidant 
burst activity of IgG immune complex stimulated neu- 
trophils. This platelet stimulatory factor appears to be 
a platelet derived adenine nucleotide (ATP, ADP). 32-33 
In conclusion, based on in vitro studies, we now 
know that many factors affect the ability of IgG im- 
mune complexes to activate phagocytic cells to produce 
oxygen radicals. The physiochemical characteristics of 
the immune complexes themselves appear important. 
Smaller, soluble immune complexes appear to be at 
least as efficient in stimulating the cells as the larger 
particulate complexes. There also appear to be complex 
relationships with other inflammatory mediators such 
as C5a, adenine nucleotides from platelets, and mac- 
rophage cytokines such as IL-1 and TNF. These me- 
diators appear to have the ability to prime immune 
complex stimulated phagocytic cells to augment their 
production of oxygen radicals (Table 2). These obser- 
vations clearly point out the complexity of the phag- 
ocytic cell activation process, and also suggest a 
possible reason why in vivo studies have implicated 
many different inflammatory mediators in the devel- 
opment of tissue injury. Many of these mediators may 
in fact be exerting their primary effect by augmentation 
of the respiratory burst of the phagocytic cells. 
B. In vivo studies on IgG immune complex 
tissue in jury 
The classic experimental models of immune com- 
plex induced tissue injury are almost exclusively 
models of IgG induced injury. The best known ex- 
amples include serum sickness, anti-GBM or nephro- 
toxic nephritis and the Arthus reaction. In the rat anti- 
GBM nephritis model, recent studies have provided 
strong evidence that reactive oxygen products from 
neutrophils are primarily responsible for the early glo- 
merular injury. 34 Treatment of animais with catalase is 
markedly protective with virtually 100% suppression 
of the proteinuria. Morphologically, as illustrated in 
Fig. 2, the glomeruli of the catalase treated animais 
appear normal even though large numbers of neutro- 
phils are present. This suggests that catalase is exerting 
its protective effect by its conversion of hydrogen per- 
oxide rather than by interfering with neutrophil 
recruitment. 
Further studies have implicated the myeloperoxi- 
dase halide products of H202 as the cause of the glo- 
merular injury. Halogenation products are present in 
the glomeruli of animais that have an immune complex 
glomerulonephritis. Furthermore, the infusion of mye- 
loperoxidase accentuates glomerular in jury.3»-36 Of in- 
Table 2. Factors which enhance the respiratory burst of immune 
complex stimulated leukocytes 
1. Chemotactic peptides (C5a), Formyl Peptides (FMLP). 
2. Proteases 
3. Cytochalasin B (neutrophils only). 





5. Macrophage derived cytokines (macrophages only). 
(a) interleukin-I (IL-l) 
(b) tumor necrosis factor (TNF) 
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Fig. 2. Illustration of the protective effects of catalase in the heterologous anti-GBM nephritis model. Neutrophils are present 
in the glomerular capillaries but there is no evidence of injury. 
terest is the fact that therapeutic interventions designed 
to either prevent the formation of the hydroxyl radical 
(.OH), or to scavenge it, have been ineffective in 
preventing experimental glomerular injury. This also 
suggests that the myeloperoxidase halide products 
of hydrogen peroxide, such as hypochlorous acid 
(HOC1-), may be more important in the pathogenesis 
of neutrophil dependent glomerular injury than the hy- 
droxyl radical. However, it must be stressed that these 
studies are preliminary and further studies are neces- 
sary to definitively resolve this question. 
Several models of IgG immune complex induced 
acute lung injury have been developed that are clearly 
oxygen radical dependent. Several years ago, our lab- 
oratory developed a model of passive immune complex 
lung injury where the IgG antibody is instilled into the 
lungs with the antigen given intravenously. Within 3 -  
4 hours an intense inflammatory reaction develops in 
the lung secondary to the in situ formation of immune 
complexes in the alveolar septae. 37 This model gives 
rapid and reproducible acute lung injury. Both com- 
plement and neutrophils are required for its develop- 
ment. In terms of neutrophil mediators, reactive 
oxygen products appear most directly responsible for 
the initiation of the lung injury.38-39 The administration 
of superoxide dismutase results in a partial protective 
effect, which is overcome in time. The mechanism of 
this partial protection appears to be that of delaying 
the recruitment of neutrophils into the site. A much 
more prominent and long lasting suppressive effect is 
seen if the animais are treated with catalase, either 
native or conjugated to polyethylene glycol. This pro- 
tection is not overcome with time. Morphologically, 
(Fig. 3), neutrophils are present in the catalase treated 
animais, but, as was also true in the glomerulonephritis 
model, no tissue injury is present. More recent studies 
have incriminated the iron dependent formation of the 
hydroxyl radical as the most critical oxidant species 
generated in this model. Treatment with iron chelating 
agents such as deferoxamine are markedly protective. 
This protective effect is overcome if iron saturated 
deferoxamine is used or exogeneous iron is admin- 
istered. 4° Therefore, the data strongly implicates the 
hydroxyl radical as the cause of the tissue injury in this 
model. This is consistent with other models of acute 
lung injury developed in our laboratory. IgA immune 
complex injury as well as other types of non-immune 
complex initiated lung injury also appear to be me- 
diated by the iron dependent formation of the hydroxyl 
radical. 41-42 Therefore, this model of IgG immune com- 
plex lung injury provides a good example of the phlo- 
gistic potential of oxygen free radicals and specifically 
the hydroxyl radical. 
Even though the IgG induced acute glomeruloneph- 
ritis and lung injury models are both oxygen radical 
mediated, the critical oxidant species incriminated dif- 
fers in the two systems. In the lung, most evidence 
suggests that the hydroxyl radical is responsible for the 
injury. In the glomerulonephritis models, on the other 
hand, we have been unsuccessful in documenting a 
role for the hydroxyl radical. Rather, there is prelim- 
inary evidence for the involvement of the myelope- 
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Fig. 3. Illustration of experimental IgG immune complex induced lung injury and the protective effects of catalase. (a) Pulmonary 
histology of an animal given IgG immune complexes. There is intense acute inflammation and hemorrhage. (b) Pulmonary 
histology of an animal given catalase in addition to the IgG immune complexes. Neutrophilic infiltrates are present in the 
interstitum but little cellular injury or hemorrhage is present. 
roxidase products of hydrogen peroxide metabolism 
such as hypochlorous acid. Obviously, further research 
needs to be done before any definitive statements can 
be made, but it does point out that immune complex 
induced, oxygen radical mediated tissue injury is not 
identical in every organ system. 
Finally, there is evidence that some experimental 
models of IgG immune complex tissue injury are not 
oxygen radical dependent. The best example of this is 
the Arthus dermal vasculitis model where superoxide 
dismutase provides a partial protective effect due to 
the apparent inhibition of neutrophil migration into the 
site. 43 However, this inhibition is transient, so that by 
the time of the maximal injury response, SOD treated 
animals show as severe a vasculitis as the nontreated 
controls. Furthermore, catalase, hydroxyl radical scav- 
engers, and iron chelators have no protective effect in 
this model. Therefore, it appears that this model of 
immune complex injury is not oxygen radical depend- 
ent. Thus, it is clear that oxidants are not responsible 
for ail types of immune complex induced tissue injury. 
Rather, other mediators such as neutrophil derived pro- 
teases or cationic proteins may be involved. 44-46 Ail of 
this serves to point out the complexity of the mediation 
of IgG immune complex induced injury. 
III. IgA IMMUNE COMPLEX INDUCED 
TISSUE IN JURY 
Recently it has become clear that IgA immune com- 
plexes initiate some human diseases. For example, the 
most common type of idiopathic glomerulonephritis 
biopsied today is associated with a predominance of 
IgA immune complexes in the glomeruli. 47 Figure 4 
illustrates IgA immune complex deposition in the 
glomerulus of a patient with Berger's IgA glomeru- 
lonephritis. IgA immune complexes are also prominent 
in such diseases as dermatitis herpetiformis and Hen- 
och-Schonlein purpura. 48 Until recently, we knew vir- 
tually nothing about the pathogenesis of IgA induced 
injury except that it appeared to differ from IgG in- 
duced injury in terms of involvement of the comple- 
ment system. Systemic complement activation appears 
not to occur in IgA mediated diseases, although im- 
munofluorescence studies do show localized comple- 
ment deposition at the site of immune complex 
deposition. Additionally, corticosteroid therapy is not 
effective in suppressing IgA mediated injury, whereas 
it is often protective in IgG induced injury. In the 
following discussion we will summarize experimental 
work illustrating the different pathogenic mechanisms 
Immune complexes and oxidants 393 
Fig. 4. Direct immunofluorescence of a renal biopsy from a patient with IgA induced glomerulonephritis showing intense IgA 
immune deposits in the mesangial regions of the glomeruh. 
involved in IgA and IgG immune complex tissue in- 
jury. However, as we shall see, both types of injury 
share an identical final pathway; the formation of re- 
active products of oxygen associated with tissue injury. 
A. In vitro studies on lgA immune complex 
stimulation of phagocytic cells 
In vitro experimental studies using IgA immune 
complexes have found striking differences in their abil- 
ity to activate phagocytic cells when compared to IgG. 
As shown in Table 3, IgA immune complexes activate 
alveolar macrophages to produce reactive oxygen prod- 
ucts at a level comparable to that of IgG immune com- 
plex stimulation. 49 However, IgA complexes, unlike 
those containing IgG, do not activate neutrophils ap- 
preciably, z6 The reason for this selective ability of IgA 
immune complexes to activate macrophages but not 
neutrophils is not understood. However, it may be due 
to the fact that IgA Fc receptors are present on mac- 
rophages? ° As detailed later, this selective macro- 
phage activation is consistent with observations ruade 
in vivo that IgA immune complex injury models require 
macrophages rather than neutrophils to mediate the 
tissue injury. 
IgA immune complex stimulation of macrophages 
can be enhanced by the addition of other inflammatory 
mediators. C5a augments superoxide anion production 
by IgA immune complex stimulated macrophages. ~8 
Furthermore, the addition of the macrophage cyto- 
kines, TNF and IL-1 also enhances superoxide pro- 
duction by IgA stimulated macrophages.26.18 (See Table 
2). Therefore, similar to IgG immune complexes, these 
inflammatory mediators prime phagocytic cells to gen- 
erate more oxidants than if IgA immune complexes 
alone are present. The obvious difference is that this 
priming effect is seen with both neutrophils and mac- 
rophages in the IgG system, whereas in IgA it occurs 
only with macrophages. These studies again support 
the in vivo observations detailed below that IgA im- 
mune complex injury is macrophage mediated. 
B. In vivo studies of lgA immune complex injury 
Recently it has been possible to demonstrate that 
IgA immune complexes induce reproducible acute tis- 
Table 3. Comparison of IgA versus IgG immune complex activation 
of rat phagocytic cells 
Cell Type Stimulus 02- (nmol/30 min) 
Neutrophils PMA* 9.3 ± 0.8 
(2 x 10 6) IgA immune complex** 1.7 - 0.4 
IgG immune complex** 9.1 -+ 0.9 
IgA alone 0.4 -+ 0.7 
IgG alone 0.6 +- 0.8 
Alveolar PMA* 9.9 ± 0.5 
Macrophages IgA immune complex** 8.4 -+ 0.5 
(5 × 105) IgG immune complex** 9.8 -+ 0.8 
IgA alone 0.7 -+ 1.0 
IgG alone 0.9 --- 0.9 
*-100 ng. 
**-30 ug 
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sue injury in the absence of involvement of other im- 
munoglobulins such as IgG or IgM. Although this now 
seems clear, there was at one time a considerable con- 
troversy over the phlogistic potential of IgA in the 
absence of these other immunoglobulins. 
In humans, the renal glomerulus is a primary target 
of IgA immune complexes. The ability of IgA immune 
complexes to induce acute glomerular injury was ini- 
tially assessed in animal experiments. Oral immuni- 
zation of mice by antigens such as bovine gamma 
globulin results in the formation of an IgA antibody to 
this foreign antigen. 51 These IgA immune complexes 
then deposit in the glomeruli, although they apparently 
do not cause renal dysfunction. This gut immunization 
model may be relevant to the study of human IgA 
immune complex diseases in that we know that some 
IgA diseases appear to be initiated by mucosal im- 
munity. In other experimental studies, investigators 
found that preformed IgA immune complexes would 
deposit in the glomeruli of animais and result in tran- 
sient hematuria. 52 However, these models ail result in 
relatively minor glomerular injury, making mediator 
studies difficult. 
Several years ago our laboratory developed a model 
of reproducible acute lung injury secondary to the for- 
mation of IgA immune complexes in the lung. 49 This 
lung injury is maximal at 3 - 4  hours and there are 
increased numbers of macrophages in the lungs of these 
animals, but virtually no neutrophils. Mediator studies 
have demonstrated that complement is required for the 
injury to occur and that neutrophil depletion has no 
effect. These depletion studies support the morpho- 
logical observations that neutrophils are not responsible 
for IgA immune complex injury. 
Even though neutrophils are not required for the 
development of IgA lung injury, experimental studies 
clearly show that oxygen radicals are responsible for 
the development of the injury. As illustrated in Fig. 
5, treatment of the animais with superoxide dismutase, 
catalase, dimethylsulfoxide (DMSO) and deferox- 
amine are all markedly protective, while iron saturated 
deferoxamine is not. 53 It cannot be determined pre- 
cisely which oxygen radical is most responsible for the 
injury. However, the strong protective effect of the 
iron chelator deferoxamine, plus the inhibitory effect 
of DMSO, provide good evidence that the formation 
of the hydroxyl radical is most critical to the evolution 
of the injury. 
IF 
Fig. 5. Experimental lgA immune complex induced lung injury. (a) An IgA immune complex treated animal with pulmonary 
macrophage accumulation and intraalveolar hemorrhage. (b) The proteetive effects of antioxidants and iron chelators in this 
model as illustrated by an animal given the iron chelator deferroxamine in addition to the IgA immune complexes. Histologically. 
the lung appears normal. 
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As mentioned above, histologic evidence suggests 
that macrophages are the critical effector cells in this 
model. This is corroborated by recent studies dem- 
onstrating that they appear to be the source of oxygen 
free radicals) 3 Markedly increased numbers of mac- 
rophages are present in the lungs of the IgA immune 
complex injured animais as assessed by the technique 
of bronchoalveolar lavage. There is also evidence of 
in vivo activation of these macrophages by the IgA 
immune complexes. Macrophages lavaged from the 
lungs of the IgA immune complex injured animais pro- 
duce high levels of superoxide and hydrogen peroxide 
spontaneously without in vitro stimulation. Further- 
more, these macrophages appear to be primed by in 
vivo contact with the IgA immune complexes, in that 
a second stimulus in vitro such as phorbol myristate 
acetate, markedly increases the formation of reactive 
oxygen products when compared to control alveolar 
macrophages) 3 Thus it seems clear that macrophages 
are the source of the oxygen radicals in this type of 
immune complex injury. This is not unexpected given 
that macrophages, being phagocytic cells, have a mem- 
brane associated NADPH oxidase system and therefore 
can produce and export high levels of reactive oxygen 
products. Furthermore, we have described another in 
vivo model of acute lung injury that is not triggered 
by immune complexes where oxygen radicals derived 
from macrophages appear to be responsible for the 
in ju ry :  ° 
In summary, IgA immune complex injury, at least 
that which occurs in the lung, is similar to IgG immune 
complex injury in that reactive oxygen products appear 
important in its evolution. However, unlike IgG com- 
plex injury, IgA induced injury seems to be mediated 
by the macrophage rather than the neutrophil. Thus, 
macrophages appear to be important in the initiation 
of some types of immune complex triggered acute tis- 
sue injury via their production and release of reactive 
oxygen products. This has important implications in 
our understanding of the pathogenesis of human im- 
mune complex diseases particularly those associated 
with the deposition of IgA. 
IV. SUMMARY 
Historically, many human diseases have been 
thought to be mediated by the formation and deposition 
of immune complexes in the affected tissues. With the 
development of the classic experimental models of im- 
mune complex induced injury such as serum sickness 
and anti-GBM nephritis, this hypothesis was strength- 
ened. These models clearly showed that circulating 
antibody complexed to antigens in the blood or formed 
against tissue antigens in situ would initiate an inflam- 
matory response in the tissues. 
Our understanding of mediators involved in the 
pathogenesis of immune complex induced injury has 
progressed markedly in the last few years. The com- 
plement system appears to be involved in many of these 
reactions, both by the generation of the chemotactic 
peptide C5a, as well as their ability to prime phagocytic 
cells when presented with a second stimulus. Under 
very specialized circumstances, complement can also 
directly induce injury by the generation of the terminal 
membrane attack complex (MAC). However, immune 
complex induced tissue injury is usually triggered by 
the activation of either neutrophils or macrophages by 
the immune complexes. Reactive oxygen products pro- 
duced by these cells appear to be central to the devel- 
opment of the tissue injury. 
While these statements are generally true, the latest 
evidence suggests that the precise mechanism of im- 
Table 4. Mediation of experimental immune complex induced tissue injury in various organ systems 
Reactive Oxygen Species Implicated 
Complement Neutrophil Macrophage 
Organ System Dependency Dependency Dependency O2 ~ H202 "OH 
I. Lung 
(A) IgG immune com- yes yes no no yes yes 
plex injury 
(B) IgA immune com- yes no yes yes yes yes 
plex injury 
II. Skin 
IgG immune complex yes yes no no no no 
injury (Arthus Reaction) 
III. Kidney 
(A) IgG immune complex 
glomerulonephritis 
1. Anti GBM nephritis yes yes no no yes no 
heterologous phase 
2. Anti GBM nephritis no no yes unknown no unknown 
autologous phase 
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m u n e  complex  i n ju ry  var ies  in d i f fe ren t  o rgan  sys tems.  
As s u m m a r i z e d  in Tab le  4, IgG and  IgA i m m u n e  com-  
plex induced  expe r imen ta l  lung  in ju ry  i nvo lves  o x y g e n  
radica ls ,  spec i f i ca l ly  the hydroxy l  radica l  ( .OH) .  How-  
ever ,  neu t roph i l s  appear  to be  the source  of  the ox idan t s  
in IgG induced  in ju ry ,  whereas  mac rophages  appear  to 
be  the source  in IgA i n d u c ed  in ju ry .  In the k i dney ,  
some expe r imen ta l  mode l s  of  g lomeru loneph r i t i s  are 
neu t roph i l  med ia t ed ,  whereas  mos t  appear  to be  mac-  
rophage  dependen t .  In the neu t roph i l  d e p e n d e n t  
mode l s ,  such as a n t i - G B M  nephr i t i s ,  reac t ive  o x y g e n  
products  in i t ia te  the in ju ry .  H y d r o g e n  perox ide  and  
perhaps  the m y e l o p e r o x i d a s e  ha l ide  products  o f  hy-  
d rogen  perox ide  are mos t  s t rongly  impl ica ted .  S tudies  
to date  in  these  la t ter  mode l s  have not  impl i ca t ed  the 
hydroxy l  radica l .  
F ina l l y ,  some  mode l s  of  i m m u n e  co mp l e x  in ju ry  
appear  no t  to be  p r ima r i l y  med ia t ed  by  o x y g e n  radical  
fo rma t ion .  In  m a c r o p h a g e  d e p e n d e n t  i m m u n e  co m plex  
mode l s  of  g l o m e r u l o n e p h r i t i s ,  p r e l i m i n a ry  s tudies  
have  so far fa i led to i n c r i m i n a t e  o x y g e n  radica ls  in the 
e v o l u t i o n  of  the g l o m e r u l a r  in ju ry .  Also ,  in the Ar thus  
reac t ion ,  r ecen t  s tudies  have  not  found  a p ro longed  
pro tec t ive  effect  for o x y g e n  radical  inh ib i to rs  or  for 
i ron chela tors .  This  suggests  aga in  that ox idan t s  are 
no t  p r imar i l y  r e spons ib l e  for the vascu la r  in ju ry  in this 
mode l .  In  fact,  p ro teases  a n d / o r  ca t ionic  pro te ins  m ay  
be more  impor t an t  in this sys tem.  
Thus ,  w h e n  desc r ib ing  the me d i a t i o n  of  i m m u n e  
complex  in ju ry ,  it is impor t an t  to r e m e m b e r  the dif-  
fe rences  and  the complex i t i e s .  It emphas i zes  the danger  
of  ex t r apo la t ing  i n f o r m a t i o n  on  i m m u n e  co mp l e x  in-  
j u r y  no t  on ly  f rom species  to species ,  bu t  also f rom 
one  o rgan  sys t em to another .  Hope fu l l y ,  fur ther  s tudies  
wil l  p rov ide  more  of  a u n i f y i n g  hypothes i s  on  the path-  
ogenes i s  o f  i m m u n e  co mp l e x  i n d u c ed  t issue in jury .  
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